We’re seeing all sorts of advances in fighting MRSA lately! AdvanSource Biomaterials Corporation recently received a patent for antimicrobial polyurethane resins, which can be used structurally or as coatings in different kinds of catheters, and are intended to help combat methicilin-resistant staphylococcus aureus (MRSA) infections.
Press release here: http://phx.corporate-ir.net/phoenix.zhtml?c=68271&p=irol-newsArticle&ID=1463328
Also, on the heels of the emergence of the NDM-1 gene, BioScience Laboratories announced that they’ve obtained seven clinical isolates of Carbapenem-Resistant (CR) Klebsiella pneumonia and Escherichia coli. BioScience Laboratories intends to use these isolates to test products for their predicted efficacy against bacteria containing the NDM-1 gene.
Press release here: http://www.24-7pressrelease.com/press-release-rss/bioscience-laboratories-announces-testing-capabilities-for-ndm1-165887.php